Cerity Partners’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$304K Sell
3,263
-1,789
-35% -$158K ﹤0.01% 2603
2025
Q4
$406K Sell
5,052
-779
-13% -$65.2K ﹤0.01% 2235
2025
Q3
$569K Buy
5,831
+161
+3% +$13K ﹤0.01% 1895
2025
Q2
$395K Buy
+5,670
New +$323K ﹤0.01% 2001
2025
Q1
Sell
-26,230
Closed -$1.86M 2478
2024
Q4
$1.86M Sell
26,230
-54,947
-68% -$4.56M ﹤0.01% 1133
2024
Q3
$8.51M Buy
81,177
+915
+1% +$107K 0.02% 538
2024
Q2
$11.4M Buy
80,262
+17,750
+28% +$2.05M 0.03% 380
2024
Q1
$6.97M Buy
62,512
+23,329
+60% +$2.78M 0.02% 560
2023
Q4
$5.08M Buy
39,183
+6,756
+21% +$931K 0.02% 534
2023
Q3
$5.29M Sell
32,427
-2,491
-7% -$438K 0.03% 411
2023
Q2
$6.4M Buy
34,918
+30,564
+702% +$4.4M 0.02% 449
2023
Q1
$580K Sell
4,354
-2,198
-34% -$258K ﹤0.01% 1226
2022
Q4
$520K Buy
+6,552
New +$462K ﹤0.01% 934

Other funds holding ACLS

Cerity Partners's ACLS Position: Q1 2026 in Review

Cerity Partners reduced its Axcelis (ACLS) stake by 35% in Q1 2026, selling an estimated $158K and leaving 3,263 shares worth $304K. The position accounts for ﹤0.01% of the portfolio, ranked #2603.

Cerity Partners first reported a position in ACLS in Q4 2022 and has held it in 13 quarters since. The position peaked at $11.4M in Q2 2024. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Cerity Partners held 3,263 shares of Axcelis worth $304K as of Q1 2026.
  • Cerity Partners sold 1,789 Axcelis shares in Q1 2026, an estimated $158K.
  • Axcelis made up ﹤0.01% of Cerity Partners's portfolio in Q1 2026, its #2603 holding.
  • Cerity Partners first reported a position in Axcelis in Q4 2022 and has held it in 13 quarters since.
  • Cerity Partners's Axcelis position peaked at $11.4M in Q2 2024.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.